These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30015978)

  • 1. Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑κB signaling pathway.
    Jiang T; Li H; Jiang R; Li H; Hou P; Chen Y; Bai J; Song J
    Oncol Rep; 2018 Sep; 40(3):1533-1544. PubMed ID: 30015978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.
    Li HL; Han L; Chen HR; Meng F; Liu QH; Pan ZQ; Bai J; Zheng JN
    Oncotarget; 2015 Aug; 6(25):21406-20. PubMed ID: 26033551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
    Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
    Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
    Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
    Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
    Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
    Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
    Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer.
    Zhou P; Li XP; Jiang R; Chen Y; Lv XT; Guo XX; Tian K; Yuan DZ; Lv YW; Ran JH; Li J; Chen DL
    Anticancer Drugs; 2019 Jul; 30(6):611-617. PubMed ID: 30789361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients.
    Wang M; Niu W; Hu R; Wang Y; Liu Y; Liu L; Zhong J; Zhang C; You H; Zhang J; Lu L; Wei L; Xiao W
    Mol Carcinog; 2019 May; 58(5):735-748. PubMed ID: 30582221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
    Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
    Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression.
    Yu G; Xiong D; Liu Z; Li Y; Chen K; Tang H
    J Cell Biochem; 2019 Oct; 120(10):17258-17272. PubMed ID: 31104316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
    Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
    Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIM3 Functions as Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer.
    Qi Q; Pan Y; Han S; Liao H; Jiang Y; Shen J; Zhong L; Wang X; Chen J
    Anat Rec (Hoboken); 2019 Sep; 302(9):1552-1560. PubMed ID: 30417983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
    Yan X; Huang L; Liu L; Qin H; Song Z
    Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed FKBP5 mediates colorectal cancer progression and sensitivity to FK506 treatment via the NF-κB signaling pathway.
    Liu T; Wang C; Xia Z
    FEBS J; 2024 Jul; 291(14):3128-3146. PubMed ID: 38602236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.